Ameliorant For Renal Insufficiency
The present invention relates to an agent for improving renal dysfunction comprising as an active ingredient a compound represented by the following formula (1): wherein each R 1 , R 2 , and R 3 represents a hydrogen atom or a methyl group, and X represents a linear or branched alkylene or alkenylene group having 10 to 28 carbon atoms.
1 . An agent for improving renal dysfunction comprising as an active ingredient a compound represented by the following formula (1):
wherein each R 1 , R 2 , and R 3 represents a hydrogen atom or a methyl group and X represents a linear or branched alkylene or alkenylene group having 10 to 28 carbon atoms.
2 . The agent for improving renal dysfunction according to claim 1 , wherein X is a linear alkylene group having 10 to 28 carbon atoms.
3 . The agent for improving renal dysfunction according to claim 2 , wherein X is a linear alkylene group having 10 to 18 carbon atoms.
4 . The agent for improving renal dysfunction according to any one of claims 1 to 3 , wherein at least one of R 1 , R 2 , and R 3 is a methyl group.
5 . The agent for improving renal dysfunction according to claim 4 , wherein each R 1 , R 2 , and R 3 represents a methyl group.
6 . Use of a compound represented by the following formula (1):
wherein each R 1 , R 2 , and R 3 represents a hydrogen atom or a methyl group and X represents a linear or branched alkylene or alkenylene group having 10 to 28 carbon atoms, for the manufacture of an agent for improving renal dysfunction.